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Hsp60, a mitochondrial chaperonin highly conserved during
evolution, has been found elevated in the cytosol of cancer
cells, both in vivo and in vitro, but its role in determining
apoptosis during oxidative stress (OS) has not yet been fully
elucidated. The aim of the present work was to study the
effects of OS on Hsp60 levels and its interactions with pro-
caspase-3 (p-C3) and p53 in tumor cells. NCI-H292
(mucoepidermoid carcinoma) cells were exposed to various
concentrations of hydrogen peroxide (H2O2) for 24 hours. Cell
viability was determined by Trypan blue and MTT assays.
DNA damage was assessed by the Comet assay, and apop-
tosis was measured by the AnnexinV cytofluorimetric test.
Exposure to increasing concentrations of H2O2 resulted in a
reduction of cell viability, DNA damage, and early apoptotic
phenomena. Hsp60, p-C3, p53, and p21 were assessed by
Western blotting and immunocytochemistry before and after
OS. Hsp60 and p-C3 were present before and after OS
induction. Immunoprecipitation experiments showed an
Hsp60/p-C3 complex before OS that persisted after it, while
an Hsp60/p53 complex was not detected in either condi-
tion. The presence of wild type (wt) p53 was confirmed by
RT-PCR, and p21 detection suggested p53 activation after
OS. We postulate that, although OS may induce early apop-
tosis in NCI-H292 cells, Hsp60 exerts an anti-apoptotic
effect in these cells and, by extension, it may do so in other
cancer cells.
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eat shock proteins (Hsps) perform critical
functions in maintaining protein homeosta-
sis under physiological and stressful condi-
tions (Ritossa, 1996; Walter and Buchner, 2002).
Hsp60, a Group I chaperonin, is found in bacteria
and eukaryotic organelles, whereas Group II chap-
eronins occur in Archea and eukaryotic cytosol, typ-
ically forming double-ringed structures (Macario et
al., 1999; 2004). At least nine genes have been
identified for Group II but only one for Group I pro-
teins in humans (Kubota et al., 1995; Hansen et al.,
2003).
Hsp60 (the mitochondrial version of it is also
called Cpn60) forms a complex with its co-chaper-
onin Hsp10 to fold and assemble proteins in the
presence of ATP (Nielsen et al., 1999). Hsp60,
including probably the mitochondrial Cpn60, can be
elevated in a number of human tumors (Czarnecka
et al., 2006; Cappello et al., 2007; 2008) and in the
extracellular milieu, which can cause activation of
an antitumor immune response (Calderwood et al.,
2007). Whether and when mitochondrial and
cytosolic Hsp60 have pro- or anti- apoptotic roles is
still unclear, since there is evidence supporting both
possibilities (Samali et al., 1999; Xanthoudakis et
al., 1999; Gupta et al., 2005;Veereshwarayya et al.,
2006; Chandra et al., 2007). In addition, it was
demonstrated that increased expression of Hsp60,
Hsp70, and Hsp90 interferes with mitochondrial
apoptotic pathways in human neuroblastoma cells
(Veereshwarayya et al., 2006).
Reactive oxygen species (ROS) have been linked
to cellular damage in various pathophysiological
disorders, such as cancer. Free radicals are recog-
nized as important players in the induction of apop-
totic cell death and necrosis. A well documented
cause of apoptosis after oxidative stress (OS) is
DNA damage. Oxygen radicals are powerful DNA
 
damaging agents. ROS cause strand breaks, alter-
ations in guanine and thymine bases, and sister
chromatid exchanges (Wiseman and Halliwell,
1996). Repair of DNA damage is mediated by p53
(Jackson et al., 2002; Lane and Crawford, 1979).
The mechanism by which p53 detects damage and
signals the induction of apoptosis is not yet fully
understood, but it has been shown that mitochon-
dria are involved (Ryan et al., 2001; Fischer et al.,
2004). It has also been demonstrated that p53 may
shift cell cycle towards apoptosis via an alternative
pathway, and that p53 directly translocates to
mitochondria in response to death signal stimuli,
e.g., hypoxia (Marchenko et al., 2000). Moreover,
the localization of p53 to mitochondria precedes
the release of cytochrome c and procaspase-3 (p-
C3) activation (Sansome et al., 2001).
In our work, we investigated the effects of OS on
Hsp60 levels and on its molecular interactions with
p-C3 and p53 in a tumor cell line, which was cho-
sen because at basal (unstressed) conditions Hsp60
is present at high levels in the cytoplasm and p53 is
present in the wild-type form.
Materials and Methods 
Cell culture and treatment protocols
NCI-H292 cells were grown as a monolayer cul-
ture with Roswell Park Memorial Institute medium
(RPMI-1640 medium, Sigma-Aldrich), supple-
mented with 10% fetal calf serum (FCS), penicillin
(100 U/ mL), streptomycin (100 µg/mL) and
amphotericin B (0.25 µg/mL), at 37°C in a 5%
CO2 atmosphere. Adherent cells were harvested by
trypsin digestion in Ca2+/Mg2+-free Hanks’ balanced
salt solution, washed with phosphate-buffered
saline (PBS) and resuspended in supplemented
RPMI medium. Cells were seeded at 1x104
cells/mL in 24-well plates. After cells reached
approximately 70% of confluence, they were ren-
dered quiescent with 1% FCS medium for 24h and
then treated with H2O2 at various concentrations (0
to 600 µM) for 24h at 37°C, according to the pro-
tocol used by Merendino et al. (2006).
Trypan blue dye exclusion and MTT assays
Cell viability was assessed by Trypan blue dye
exclusion (TB) and MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide) assays
(Strober, 2001; Hayon et al., 2003). For the TB
assay, 10 µL of the cell suspension was mixed with
10 µL of TB, aliquots were placed on a counter
chamber, and cells were differentially counted under
the microscope. For the MTT assay, a 20 µL solu-
tion of 5 mg/mL MTT dissolved in PBS was added
to the cells that were cultured for 5h at 37ºC. The
medium was removed, 200 µL of DMSO added and
crystals dissolved. Absorbance was measured at
550 nm with a plate reader.
Comet assay
The single-cell gel electrophoresis or “Comet
assay” was performed according to the original pro-
tocols of Singh et al. (1988). Following treatments,
the medium was removed. The cells were washed
with ice-cold PBS and trypsinized with 1% trypsin
in Ca2+/Mg2+-free Hanks’ balanced salt solution.
After 3 min at 37°C, complete medium was added
and the cells gently resuspended. Slides were pre-
pared with 1% normal melting agarose (NMA).
Approximately 10,000 cells were mixed with 85 µL
of low melting point (LMA, 0.7%) agarose at 37%
and applied to the prepared slides. The slides were
immersed in a lysing solution made of 2.5 M NaCl,
0.1M Na2EDTA, 10–2 M Tris-HCl, 1% sodium sar-
cosinate, pH 10, with 1% Triton X-100 and 10%
DMSO added just before use.The cells were kept at
4°C, in the dark, for at least 1h for lysing and pro-
moting DNA unwinding. The slides were removed
from the lysing solution, drained and placed on a
horizontal gel electrophoresis unit, side by side.The
tank was filled with chilled fresh alkaline solution
(10–3 M Na2 EDTA, 0.3 M NaOH) at 4°C and pH
12.8, Before electrophoresis, the slides were left in
the solution for 20 min to allow for completion of
DNA unwinding. Electrophoresis was conducted in
alkaline buffer at 4°C for 20 min, at 25V and
300mA. After electrophoresis, slides were gently
washed in a neutralization buffer (0.4 M Tris-HCl,
pH 7.5) to remove alkali and detergent, and stained
with 50 µL DAPI (5 µg/mL) in Vectashield
(mounting medium for fluorescence H-1000,
Vector Laboratories, USA). Microscope slides were
viewed using a Leica fluorescence microscope.
Image analysis was performing using the TriTek
CometScore Freeware Software (http://www.
tritekcorp.com/products_cometscore.php).The tail-
length was measured in 50 comets per slide.
Scoring was done with a double blind approach.
Each slide was coded and measurement of DNA
damage was performed by an observer who was
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unaware of the treatment group from which the
sample was derived. Statistical analysis was per-
formed by ANOVA test; a p<0.05 was considered
as significant.
Determination of apoptosis by flow cytometry
Apoptosis was measured according to the tech-
nique of Vermes et al. (1995); AnnexinV (AxV) was
used to detect phosphatidylserine externalisation on
the outer leaflet of the plasma membrane of apop-
totic cells. NCI-H292 cells were treated with 
200 µM and 400 µM of H2O2 for 24h. Adherent
cells were harvested by trypsin digestion in
Ca2+/Mg2+-free Hanks’ balanced salt solution. After
washing twice in cold PBS, the cells were resus-
pended at a density of 1x105 cells/100 µL of bind-
ing buffer (10 mM HEPES pH 7.4, 140 mM NaCl,
2.5 mM CaCl2) in 5ml propylene FACS tubes. AxV-
FITC (1 µg/mL) and Propidium Iodide (PI) (2.5
µg/mL) were added to the tubes and incubated in
the dark for 15 min, and then 400 µL of cold bind-
ing buffer was added and the cells were analysed
using a FACScan flow cytometer. The degree of
early apoptosis was expressed as the number of
AxV+/PI– cells shown as a percentage of total cells.
The late apoptotic cells were characterised as
AxV+/ PI+, and necrotic cells as PI+. Experiments
were performed in quintuplicate. Statistical analy-
sis was performed by ANOVA test; a p<0.05 was
considered as significant.
Preparation of total cell lysates and protein assays
The harvested cells were treated with 0.25%
trypsin and 1 mM of EDTA and centrifuged at
2,000 rpm. Pellets were washed in PBS two times.
Subsequently, the cells were resuspended in lysis
buffer containing 50 mM Tris/HCl, 150mM NaCl,
1% NP-40, 1 mM EGTA and protease inhibitors
(1 mM AEBSF, 1 µM Aprotinin, 50 µM Bestatin,
15 µM E-64, 20 µM Leupeptin, 10 µM Pepstatin
A). Cell lysates were then incubated for 30 min on
ice and then sonicated for 3-5 seconds on ice and
then centrifuged at 13,000 rpm for 10 minutes.
Total proteins were detected using the Bio-Rad Dc
Protein Assay kit. Protein concentrations were
determined by comparing the absorbance value
with a known value based on a calibration curve, for
bovine serum albumin (BSA). The samples were
mixed with vortex and incubated for 15 minutes in
the dark.The absorbance was measured at 750 nm.
Polyacrylamide gel electrophoresis and Western
blot analyses
Proteins were separated by electrophoresis on
denaturing 12% polyacrylamide gel (SDS-PAGE).
Equal amounts of proteins (25 µg) were loaded on
to each lane and transferred to PVDF membranes
(HY Bond-P Amersham Biosciences). The specific
binding of antibodies was detected using ECL®
(Amersham Biosciences) and mouse monoclonal
antibodies made against human Hsp60 (clone LK1,
Sigma, 1:1000), human procaspase-3 (clone E-8,
Santa Cruz, 1:1000), human p53 (clone DO-7,
Dako, 1:500), or human p21(clone 187, Santa
Cruz, 1:1000). Experiments were performed in
triplicate.
Immunocytochemistry
Cells for immunocytochemistry were fixed in
methanol. Immunostaining by the streptavidin-
biotin complex method (LSAB2 Kit peroxidase,
DAKO) was performed using the same mouse pri-
mary monoclonal antibodies described above, at the
following dilutions: anti-Hsp60 (clone LK1, Sigma,
1:300), anti-human procaspase-3 (clone E-8,
Santa Cruz, 1:100), anti-human p53 (clone DO-7,
Dako, 1:100), and anti-human p21(clone 187,
Santa Cruz, 1:100). Experiments were performed
in triplicate.
Immunoprecipitation
Immunoprecipitation to detect protein complexes
(i.e., proteins co-precipitating together) was per-
formed with 5 µg of primary antibody per 1 mL of
total cell lysate, incubated overnight at 4°C with
gentle rotation. The primary mouse monoclonal
antibodies used were the same as those described
above. Antibody/protein complexes were immuno-
precipitated with antibodies linked to sepharose A
beads 4 fast few® (Amersham Biosciences). Non-
specifically bound proteins were removed by repeat-
edly washing with isotonic lysis buffer.
Immunoprecipitated proteins were resolved by
SDS-PAGE. Experiments were performed in tripli-
cate.
RNA extraction
Total cellular RNA was extracted from cells at
70% confluence that had been treated with H2O2 at
200 µM or 400 µM concentrations for 24 h.Total
cellular RNA was extracted and isolated by using a
kit based on the disruptive and protective proper-
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ties of Guanidinium Thiocyanate followed by selec-
tive precipitation with Lithium Chloride and
Caesium Trifluoroacetate (QuickPrep Total RNA
Extraction Kit, Amersham Biosciences). The yield
of RNA was quantified spectrophotometrically by
measuring absorption at 260 nm.
RT-PCR
RT-PCR was conducted in a two-step reaction
(reverse transcription, followed by PCR) by using
Ready-to-Go RT-PCR Beads (Amersham Bio-
sciences). In the first step, 1 µg of total RNA was
primed with a random primer. cDNA was poly-
merised at 42°C for 30 min and the double-strand-
ed RNA:cDNA heteroduplex was denatured at
95°C for 5 min to allow the cDNA to be used as a
template for polymerisation in the second step.
PCR amplification of cDNA was performed adding
to the reaction specific primers for p53. The for-
ward primer sequence was 5’- GTT CCG AGA GCT
GAA TGA GG - 3’ and the reverse primer was 5’ -
CTG AGT CAG GCC CTT CTG TC - 3’.The product
of PCR was a fragment of 158 bp. mRNA was nor-
malized to the amount of beta-actin mRNA, which
was used as a basal, housekeeping gene product for
each experimental condition. The PRC reactions
were cycled at 95°C for 30 s, 60°C for 60 s, 72°C
for 60 s, with a final extension at 72°C for 5 min.
RT-PCR products were separated and visualized on
2% agarose gel with the ethidium bromide stain.
Experiments were performed in triplicate.
Results 
Inhibition of growth in cells exposed to H2O2
To determine whether H2O2 induced cell-death in
our system, we cultured NCI-H292 cells in RPMI
supplemented with varying concentrations of H2O2
(0 to 600 µM). After 24h, exposure to increasing
concentrations of H2O2 determined a dose-depend-
ent reduction of cell viability as shown by MTT and
TB assays (Figure 1A).
DNA damage
DNA damage in NCI-H292 cells was determined
by the Comet assay after a 1h treatment with 
200 µM or 400 µM of H2O2. After treatments, the
cells showed typical comets, which were absent in
the cells that had not been treated with H2O2
(Figure 1 B, insets). We used the TriTek Comet
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Figure 1. (A) NCI-H292 cell viability at various H2O2 concentra-
tions for 24 hours. Lines indicate results from trypan blue (TB)
(l) and MTT (n) cell viability tests. Vertical axis, cell viability
index; horizontal axis, concentration of H2O2 in µM (w/o indi-
cates untreated cells). Both TB and MTT tests gave analogous
results, demonstrating a dose-dependent decrease of cell viabil-
ity. (B) Induction of DNA damage in NCI-H292 cells by H2O2 treat-
ment: evaluation by comet assay. The bar graphs show DNA
damage percentages obtained by software TriTek Comet Score
(see text for further details); *represents statistically signifi-
cant difference (p<0.05) when datasets (tail moment and tail
DNA) were compared between treated and untreated cells; +rep-
resents significance (p<0.05) when datasets (tail moment and
tail DNA) were compared between 200 µM and 400 µM. Insets
show untreated cells (w/o, upper right) and cells treated with
400 µM of H2O2 (lower right). Magnification 100X. 
C) Evaluation of apoptotic phenomena after H2O2 treatments by
flow cytometry. The bar graphs (upper left) show the percent-
ages of NCI-H292 apoptotic cells in untreated (W/O) and treat-
ed (200 µM and 400 µM of H2O2) cells. The percentage of cells
in early apoptosis increased significantly (*) at both 200 µM and
400 µM concentrations of H2O2 (see text for further details).
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score to analyze both tail moment and tail DNA, to
assess DNA damage, and found a significant
(p<0.05) increment of both values after H2O2 treat-
ment (Figure 1 B).
Induction of apoptosis in NCI-H292cells by H2O2:
evaluation by flow cytometry
To verify whether H2O2 was able to trigger apop-
tosis in the NCI-H292 cells, we evaluated the pres-
ence of phosphatidylserine on their surface using
FITC-conjugated AxV. After 24h incubation with
H2O2, the number of PI– and AxV+ cells significant-
ly increased when NCI-H292 cells were treated
with 200 µM or 400 µM of H2O2. In untreated
cells, the percentage of cells in early apoptosis was
3.57±0.81%; when the cells were treated with 200
µM or 400 µM of H2O2, the percentage of cells in
early apoptosis increased significantly, to
50.69±2.098% (p<0.01) and 46.24±2.90%
(p<0.02), respectively (Figure 1C).
Expression of Hsp60/p53/ p21/p-C3
Hsp60 and p-C3 were expressed before and after
H2O2 treatments according to Western blotting and
immunocytochemistry data (Figure 2); also p53 did
not change after H2O2 treatments: it was expressed
at very low levels in untreated cells as well as in
cells exposed to 200 µM or 400 µM of H2O2, (not
Figure 2. On the left side are shown representative Western blottings and immunocytochemical (original magnifications: 400x) pictures
for Hsp60 (top), p21 (middle), and pro-C3 (bottom). W/O: untreated cells; 200: cells treated with 200 µM of H2O2; 400: cells treated with
400 µM of H2O2; quantification of protein levels was obtained normalising for β-actin and it is showed on the right side of the panel. Hsp60
and pro-C3 were present in untreated and treated cells, while p21 was detectable only after treatment; p53 was undetectable by neither
Western blotting nor immunocytochemistry under all conditions tested (not shown), but it was detectable by RT-PCR (Figure 3).
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shown); because of these results, we decided to per-
form RT-PCR experiments (see below) to verify
p53 presence before and after treatments. p21 was
detected after H2O2 stimulations, as shown by both
immunocytochemistry and western blotting (Figure
2).
RT-PCR and immunoprecipitation analyses
Expression of p53 was demonstrated by RT-PCR
in all experimental conditions (untreated and treat-
ed cells) tested (Figure 3 A, B). Co-immunoprecip-
itation studies performed on total cell lysates
showed that p-C3 co-precipitated with Hsp60 both
in untreated and treated cells (Figure 3 C). In con-
trast, p53 did not co-precipitate with Hsp60 under
any of the conditions tested (data not shown).
Discussion
Hsps are an evolutionary conserved family of
functionally related proteins, and many of them are
molecular chaperones (Ellis, 1990; Ritossa, 1996;
Walter and Buchner, 2002; Macario et al., 1999;
2004; Young et al., 2004). These are capable of
recognizing and binding substrate proteins in an
unstable or inactive state and assisting them in
folding or refolding to achieve a native conforma-
tion. Hsps form an ancient anti-stress, defence sys-
tem in all living organisms on earth, mediating a
wide range of intracellular activities, and their
expression can be induced by a variety of stressors
including apoptotic stimuli. Hsp60 is a chaperonin
localized to the inner mitochondrial membrane and
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Figure 3. (A) Detection of p53
mRNA by RT-PCR. Lanes: 1, 100-
1,000 bp-size marker; 2, internal
positive control; 3, p53 in untreat-
ed cells; 4, p53 in cells treated
with 200 µM of H2O2; 5, p53 in
cells treated with 400 µM of H2O2;
6, β-actin in untreated cells; 7, β-
actin in cells treated with 200 µM
of H2O2; 8, β-actin in cells treated
with 400 µM of H2O2. (B) The bar
graphs show quantification of p53
mRNA levels normalised for β-
actin. (C) Co-immunoprecipitation
tests in total cell lysates for
Hsp60/p53 (left subpanel) and
Hsp60/procaspase-3 (right sub-
panel) complexes. Lanes from left
to right in each subpanel: 1,
untreated cells; 2, cells treated
with 200 µM of H2O2; 3, cells treat-
ed with 400 µM of H2O2.
Immunoprecipitation was carried
out using antibodies against p53
followed by Western blotting with
antibodies to Hsp60 (left subpan-
el), or using antibodies against pro-
caspase-3 followed by Western
blotting with antibodies to Hsp60
(right subpanel). The Hsp60/pro-
caspase-3 complex was detected
under all conditions tested while
no Hsp60/p53 complex was
observed.
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matrix and, less frequently, to extramitochondrial
sites (Soltys and Gupta, 1996, 1997, 1999;
Cappello et al., 2008). Hsp60 is constitutively
expressed under normal conditions, but its levels
can increase (as determined by immunohistochemi-
cal methods for example) in pre-neoplastic lesions
(Cappello et al., 2002, 2003a, 2003b; Fan et al.,
2006) and in many advanced cancers (Schneider et
al., 1999; Cappello et al., 2005; Urushibara et al.,
2007). The main function of the mitochondrial
Hsp60 is considered to be assistance in the folding
and degradation of mitochondrial proteins (Garrido
et al., 2001; Levy-Rimler et al., 2002; Fersht and
Daggett, 2002; Parcellier et al., 2003).The involve-
ment of Hsp60 in the process of apoptosis and
tumorigenesis is still under debate. In a recent
work, Chandra et al. (2007) showed that Hsp60,
when it accumulates in the cytosol of tumor cells
with significant mitochondrial release, possesses a
pro-apoptotic function. In contrast, when Hsp60
accumulates in cytosol without mitochondrial
release, it exerts an anti-apoptotic effect. The pro-
death role of Hsp60 seemed to involve caspase-3
maturation but when Hsp60 played a pro-survival
role, it did not associate with active caspase-3
(Chandra et al., 2007).
The aim of the present work was to explore
whether Hsp60 interacts with p-C3 and p53 in a
cancer model system submitted to OS, a type of
stress known to occur in many tumors, causing not
only nuclear but also mitochondrial and cytosolic
damage (Renis et al., 1996; Grasso et al., 2003).
For this purpose, the tumor cell line NCI-H292 was
chosen as a model system and studied before and
after OS induction with H2O2.
We found that Hsp60 is present in untreated and
treated NCI-H292 cells, as shown by immunocyto-
chemistry and Western blotting. These results,
together with the demonstration of an Hsp60/p-C3
complex before and after OS, support the hypothe-
sis that Hsp60 has an anti-apoptotic role in NCI-
H292 cells. The levels of p53 were very low in
Western blotting tests, below a detectable threshold
by immunocytochemistry; these results are typical-
ly obtained when p53 is in the wild-type form, since
it has a short half-life. However, p53 was clearly
demonstrated by RT-PCR, which together with the
demonstration (by immunocytochemistry and
Western blotting) of p21 expression after OS,
strongly supports the notion that p53 activation
had occurred after OS. Contrary to our expectation,
we did not find an Hsp60/p53 complex neither
before nor after OS, disproving our initial hypothe-
sis that these molecules could interact in our model
system.
In conclusion, our experiments show that after an
OS that causes nuclear damage and activation of
p53, the Hsp60/p-C3 complex persists and the lat-
ter can have an anti-apoptotic effect. By contrast,
no Hsp60/p53 complex was present in our model.
Further in vitro experiments are in progress to test
this hypothesis, which, if confirmed, would provide a
basis for using Hsp60 as a target for antitumoral
therapy (Cappello et al., 2007; 2008).
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